"Building a Bright Future for Polish Clinical Research. We Can Do It Together!"

A strategic meeting of thought leaders, clinical trial experts, and regulatory stakeholders to discuss and set a course of action for enhancement of the regulatory landscape for the conduct of clinical trials in Poland.

SEMINAR STARTS IN

Days
Hours
Minutes
Seconds

June 16th, 2025, 10:00 AM CET

Free seminar by personalized invitation only

"Building a Bright Future for Polish Clinical Research. We Can Do It Together!"

This event will gather approximately 60 key representatives of our industry, including participants from the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL), the Supreme Bioethics Committee, and leaders from not-for-profit and industry associations, such as GCPpl, POLCRO, and Infarma. The meeting will be chaired by Dr. Ingrid Klingmann, a recognized European moderator for multi-stakeholder discussions and expert in clinical research methodology, regulatory affairs and ethics.

We will focus on jointly identifying actionable solutions for the Polish regulatory landscape by drawing on proven European and other countries’ national strategies to help accelerating the approval process. We aim at initiating a coordinated and impactful dialogue supported by data, legal insights, and economic analysis, leading to a joint position and recommendations paper.

The event space will be arranged to foster

1

Open dialogue and facilitate networking

2

Central presentation zone in a theatre-style setup

3

Cocktail tables for networking

4

Buffet with breakfast menu.

Speakers

Ingrid-Klingmann

Ingrid Klingmann, M.D., Ph.D.

SPEAKER

Physician with 30+ years of experience in clinical research, regulatory strategy, and early-phase trial design. Leads a consultancy for site management and development, and lectures at European universities.

Ronald Koening

Ronald Koning M.D., NP

 SPEAKER

Medical doctor with 36+ years of experience in clinical development and general management across phases I–IV and multiple therapeutic areas. Worked with leading pharma (Abbott, Schering Plough), biotech (Amgen), and CROs (Kendle, INC). Holds an MD from Erasmus University, with clinical background in internal medicine and cardiology.

Michal Zmyslowski

Michał Zmysłowski, MSc, EMBA

SPEAKER

Associate Director Clinical Operations,
Site Management/Clinical Operations,
R&DS, IQVIA
Group leader for quality and training POLCRO.

Olga Zielinska

Olga Zielińska, Lawyer

SPEAKER

Legal expert with over 13 years of experience in clinical trials. She represented the Polish Ministry of Health in EU working groups on clinical trials (2012–2018) and co-authored the national Clinical Trials Act implementing the CTR. Currently, she provides legal and regulatory support at CRO Pure Clinical and serves as a legal advisor for Global Certification Body - an organization focused on quality and compliance across various industries. She is also a recognized GDPR expert.

Patronage

Events

Nov 2021
Apr 2024
Jun 2024
April 2025
Challenges in conducting phase 1 trials in pandemic time
Are you ready for the FDA?
Navigating the EU Biosimilar Development Pathway
QTc Unlocked: Advanced Approaches to Cardiac Safety & Modelling in Clinical Trials

How to get there

Varso Tower, Chmielna 69, 00-801 Warszawa
Entrance and reception from Jana Pawła 2 St.
Paid underground parking – entrance from Chmielna St.

To ensure the best possible experience, the website contains cookies. Please read our privacy policy.